These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 813934)

  • 41. Analysis of the mechanism of allograft rejection and cell-mediated immunity. II. Divergent effect of CY pretreatment on the generation of cytotoxic activity in the draining lymph nodes and spleen.
    Nanishi F; Taniguchi K; Kubo C; Onoyama K; Omae T; Nomoto K
    J Clin Lab Immunol; 1983 Sep; 12(1):23-30. PubMed ID: 6631941
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Study of the effect of single or multiple doses of BCG on antibody-dependent cellular cytotoxicity.
    Kiger N; Bruley-Rosset M; Huchet R; Mathe G
    Immunology; 1980 Nov; 41(3):687-94. PubMed ID: 6970164
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immune response to a syngeneic mammary adenocarcinoma. III. Development of memory and suppressor functions modulating cellular cytotoxicity.
    Kuperman O; Fortner GW; Lucas ZJ
    J Immunol; 1975 Nov; 115(5):1282-7. PubMed ID: 1176776
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The morphologic basis of humoral immune responses.
    La Via MF
    Pathobiol Annu; 1971; 1():241-60. PubMed ID: 4950381
    [No Abstract]   [Full Text] [Related]  

  • 45. Cooperation and cell-mediated cytotoxicity as functions of two subsets of T cells.
    Dennert G; Lennox ES
    J Immunol; 1974 Nov; 113(5):1553-61. PubMed ID: 4213868
    [No Abstract]   [Full Text] [Related]  

  • 46. Allograft immunity in the mouse. 1. Quantitation and specificity of cytotoxic effector cells after in vitro sensitization.
    MacDonald HR; Phillips RA; Miller RG
    J Immunol; 1973 Aug; 111(2):565-74. PubMed ID: 4123983
    [No Abstract]   [Full Text] [Related]  

  • 47. Selective modulation by alpha-difluoromethylornithine of T-lymphocyte and antibody-mediated cytotoxic responses to mouse tumor allografts.
    Ehrke MJ; Porter CW; Eppolito C; Mihich E
    Cancer Res; 1986 Jun; 46(6):2798-803. PubMed ID: 3084078
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factors affecting suppressor cell activity in tumor-allosensitized mice.
    Argyris BF
    J Natl Cancer Inst; 1980 Apr; 64(4):959-66. PubMed ID: 6445017
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhancement of tumour growth by lymphoid cells from mice treated with antilymphocyte globulin.
    Shellam GR; Fahey KJ
    Adv Exp Med Biol; 1973; 29(0):411-7. PubMed ID: 4211985
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of stimulation and blockade of mononuclear phagocyte system on the delayed footpad reaction to SRBC in mice.
    Yoshikai Y; Miake S; Matsumoto T; Nomoto K; Takeya K
    Immunology; 1979 Nov; 38(3):577-83. PubMed ID: 521054
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recombinant interleukin 12 enhances cellular immune responses to vaccination only after a period of suppression.
    Kurzawa H; Wysocka M; Aruga E; Chang AE; Trinchieri G; Lee WM
    Cancer Res; 1998 Feb; 58(3):491-9. PubMed ID: 9458095
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of chronic daily cyclophosphamide administration on established antibody responses.
    Gagnon RF; MacLennan IC
    Clin Exp Immunol; 1981 Oct; 46(1):178-84. PubMed ID: 7337968
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A; Nowicky JW
    Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modulation of cell-mediated alloimmunity by BCG. I. Antagonism and potentiation of immunosuppression caused by cytarabine.
    Murahata RI; Mitchell MS
    J Natl Cancer Inst; 1982 Sep; 69(3):607-12. PubMed ID: 6981020
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characteristics of murine non-specific killer cells induced in vivo by recombinant human interleukin-2.
    Hinuma S; Naruo K; Shiho O; Tsukamoto K
    Immunology; 1986 Oct; 59(2):251-9. PubMed ID: 3490435
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quantitation of the cell-mediated immune response. I. The number of cytolytically active mouse lymphoid cells induced by immunization with allogeneic mastocytoma cells.
    Henney CS
    J Immunol; 1971 Dec; 107(6):1558-66. PubMed ID: 5000987
    [No Abstract]   [Full Text] [Related]  

  • 57. Differential interference by azathioprine and 6-mercaptopurine with antibody-mediated immunoregulation: synergism of azathioprine and antibody in the control of an immune response.
    Medzihradsky JL; Klein C; Elion GB
    J Immunol; 1982 Jul; 129(1):145-9. PubMed ID: 6177747
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Induction of IgG memory responses with polyvinylpyrrolidone (PVP) is antigen dose dependent.
    Lite HS; Braley-Mullen H
    J Immunol; 1981 Mar; 126(3):928-33. PubMed ID: 7462637
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low doses of IL-4 injected perilymphatically in tumor-bearing mice inhibit the growth of poorly and apparently nonimmunogenic tumors and induce a tumor-specific immune memory.
    Bosco M; Giovarelli M; Forni M; Modesti A; Scarpa S; Masuelli L; Forni G
    J Immunol; 1990 Nov; 145(9):3136-43. PubMed ID: 2212677
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibody-dependent cell-mediated cytotoxicity: heterogeneity of effector cells in human peripheral blood.
    MacDonald HR; Bonnard GD; Sordat B; Zawodnik SA
    Scand J Immunol; 1975 Sep; 4(5-6):487-97. PubMed ID: 52180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.